Role of Human Epididymis Protein 4 in Tumour Angiogenesis
Authors:
- Harshita DubeyHDHarshita Dubey
- Mansi ModiMMMansi Modi
- Saransh VermaSVSaransh Verma
- Ruchi SinhaRSRuchi Sinha
- Harsh GoelHarsh Goel
- Amar RanjanARAmar Ranjan
- Pranay TanwarPTPranay Tanwar
- Anita ChopraACAnita Chopra
- Ekta RahulEREkta Rahul
- Lawanya RanjanLRLawanya Ranjan
- Neeraj VermaNVNeeraj Verma
- Devender Singh ChauhanDCDevender Singh Chauhan
Open Access
- 18 January 2023
- book chapter
- Published by IntechOpen
Abstract
HE4 is a secretory protein. It is expressed in reproductive tract and respiratory epithelium in normal individuals. Serum level of HE4 is raised in various solid cancers that give us an advantage to use it as a diagnostic and prognostic biomarker. It is an established biomarker of epithelial ovarian cancer [EOC]. It has also shown the significance in various other malignancies like cancer of endometrium, cervix, lung and breast. Studies show HE4 as an independent prognostic biomarker in non-small cell lung carcinoma. Its raised values in cancer signify its role in oncogenesis. HE4 promotes angiogenesis via STAT3 signalling pathway. In this paper we have tried to illustrate about human epididymis protein 4 and its role in tumour angiogenesis.Keywords
This publication has 50 references indexed in Scilit:
- Significance of HE4 estimation in comparison with CA125 in diagnosis of ovarian cancer and assessment of treatment responseDiagnostic Pathology, 2013
- High preoperative blood levels of HE4 predicts poor prognosis in patients with ovarian cancerJournal of Ovarian Research, 2012
- Serum Human Epididymis Protein 4 and Risk for Ovarian Malignancy Algorithm as New Diagnostic and Prognostic Tools for Epithelial Ovarian Cancer ManagementCancer Epidemiology, Biomarkers & Prevention, 2011
- Tumor-Recruited Neutrophils and Neutrophil TIMP-Free MMP-9 Regulate Coordinately the Levels of Tumor Angiogenesis and Efficiency of Malignant Cell IntravasationThe American Journal of Pathology, 2011
- HE4 a novel tumour marker for ovarian cancer: comparison with CA 125 and ROMA algorithm in patients with gynaecological diseasesTumor Biology, 2011
- Serum HE4 concentration differentiates malignant ovarian tumours from ovarian endometriotic cystsBritish Journal of Cancer, 2009
- Carcinoma of the OvaryInternational Journal of Gynecology & Obstetrics, 2006
- Comprehensive analysis of HE4 expression in normal and malignant human tissuesLaboratory Investigation, 2006
- The putative ovarian tumour marker gene HE4 (WFDC2), is expressed in normal tissues and undergoes complex alternative splicing to yield multiple protein isoformsOncogene, 2002
- A Major Human Epididymis-Specific cDNA Encodes a Protein with Sequence Homology to Extracellular Proteinase Inhibitors1Biology of Reproduction, 1991